The nitrosterols - A step forward from the steroid anti-inflammatory drugs?

Expert Opinion on Investigational Drugs

Volumn 14, Issue 7, 2005, Pages 823-828

  Doggrell, Sheila A ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

Author keywords

Inflammation; Nitrosterols; NO releasing flunisolide; NO releasing hydrocortisone; NO releasing prednisolone

Indexed keywords

21 (4' NITROOXYMETHYL)BENZOATE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; [PREDNISOLONE 21 (4' NITROOXYMETHYL)BENZOATE]; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; DIETHYLENE DIAZENIUMDIOLATE; FLUNISOLIDE; GLUCOCORTICOID; HEAT SHOCK PROTEIN 90; HYDROCORTISONE; HYDROCORTISONE 21 (4' NITROOXYMETHYL)BENZOATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NCX 1015; NCX 1022; NCX 1024; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PREDNISOLONE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CHRONIC INFLAMMATION; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; ENTERITIS; FRAGILITY FRACTURE; HUMAN; HYPERTENSION; IN VIVO STUDY; MONOTHERAPY; NITRATION; NITROSYLATION; NONHUMAN; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONITIS; PROTEIN CONTENT; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SKIN INFLAMMATION; STRUCTURE ANALYSIS; ULCERATIVE COLITIS; WASTING SYNDROME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUGS, INVESTIGATIONAL; FLUOCINOLONE ACETONIDE; HUMANS; HYDROCORTISONE; NITRIC OXIDE; PREDNISOLONE;

EID: 22744447347     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.14.7.823     Document Type: Review

References (21)

1. MONCADA S, PALMER RM, HIGGS EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. (1991) 43:109-142.
2. MOILANEN E, VAPAATALO H: Nitric oxide in inflammation and immune response. Ann. Med. (1995) 27:359-367.
3. KOLIOS G, VALATAS V, WARD SG: Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology (2004) 113:427-437.
4. WALLACE JL, CIRINO G: The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs. Trends Pharmacol Sci. (1994) 15:405-406.
5. DIMMELER S, HAENDELER J, NEHLS M, ZEIHER AM: Suppression of apoprosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteines protease (CPP)-32-like proteases. J. Exp. Med. (1997) 185:601-607.
6. FIORUCCI S, ANTONELLI E, SANTICCO L et al.: Gastrointestinal safety of nitric-oxide releasing aspirin is related to inhibition of ICE-like cysteines proteases in rats. Gastroenterology (1999) 116:1089-1106.
7. H1-like cytokines. Gastroenterology (2000) 118:404-421.
8. HOGABOAM CM, BEFUS AD, WALLACE JL: Modulation of mast cell reactivity by IL-1β. Divergent effects on nitric oxide and platelet-activating factor release. J. Immunol. (1993) 151:3767-3774.
9. BARNES PJ: Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci.. (1998) 94:557-572.
10. TAMURA Y, OKINAGA H, TAKAMI H: Glucocorticoid-induced osteoporosis. Biomed. Pharmacother. (2004) 58:500-504.
11. PAUL-CLARK M, DEL SOLDATO P, FIORUCCI S, FLOWER RJ, PERRETTI M: 21-NO-prednisolone is a novel nitric-oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. Br. J. Pharmacol. (2000) 131:1345-1354.
12. BARALDI PG, ROMAGNOLI R, DEL CARMEN NUNEZ M et al.: Synthesis of nitro esters of prednisolone, new compounds combining pharmacological properties of both glucocorticoids and nitric oxide. J. Med. Chem. (2004) 47:711-719.
13. PAUL-CLARK MJ, MANCINI L, DEL SOLDATO P, FLOWER RJ, PERRETTI M: Potent antiarthritic properties of a glucocorticoid derivative, NCX-1015, in an experimental model of arthritis. Proc. Natl. Acad. Sci. (2002) 99:1677-1682.
14. PAUL-CLARK MJ, ROVIEZZO F, FLOWER RJ et al.: Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands. J. Immunol. (2003) 171:3245-3252.
15. TURESIN F, DEL SOLDATO P, WALLACE JL: Enhanced anti-inflammatory potency of a nitric oxide-releasing prednisolone derivative in the rat. Br. J. Pharmacol. (2003) 139:966-972.
16. FIORUCCI S, ANTONELLI E, DISTRUTTI E et al.: NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propia and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Proc. Natl. Acad. Sci. (2002) 99:15770-15775.
17. DI FILLIPPO C, ROSSI F, ONGINI E et al.: The distinct alterations produced in cardiovascular functions by prednisolone and nitro-prednisolone (NCX-1015) in the rat highlight a causal role for endothelin-1. J. Pharmacol. Exp. Ther. (2004) 310:1133-1141.
18. WALLACE JL, RISSO G, CIRINE G, DEL SOLDATO P, FIORUCCI S: Enhanced anti-inflammatory potency of a nitric oxide-releasing derivative of flunisolide: role of nuclear factor-κB. J. Pharmacol. Exp. Ther. (2004) 310:1096-1102.
19. ELLISON JA, PATEL L, RAY DW, DAVID TJ, CLAYTON PE: Hypothalamic-pituitary-adrenal function and glucocorticoid sensitive in atopic dermatitis. Pediatrics (2000) 105:794-799.
20. HYUN E, BOLLA M, STEINHOFF M et al.: Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis. Br. J. Pharmacol. (2004) 143:618-625.
21. KRÖNCKE K-D, SUSHEK CV, KOLB-BACHOFEN V: Implications of inducible nitric oxide synthase expression and enzyme activity. Antioxid. Redox. Signal. (2000) 2:585-605.